Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report
Psychopharmacology Bulletin · 2026
DOI: 10.64719/pb.18543 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychopharmacology Bulletin, 2026. Verfasst von Rim Sellami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sellami, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Mianserin, Antidepressive Agents, Tricyclic. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We report the case of a 27-year-old male who developed elevated liver enzymes during treatment with low-dose mirtazapine for insomnia. Liver function normalized after discontinuation of the drug, supporting a probable drug-induced liver injury (DILI). This case highlights the need for hepatic monitoring during mirtazapine therapy, even at low doses and in asymptomatic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sellami, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia.
- Feki, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia.
- Masmoudi, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia.
Zitieren
APA
Sellami, R., Feki, I., & Masmoudi, J. (2026). Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.18543
Vancouver
Sellami R, Feki I, Masmoudi J. Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report. Psychopharmacology Bulletin. 2026. doi:10.64719/pb.18543
BibTeX
@article{Sellami2026,
author = {Sellami, Rim and Feki, Ines and Masmoudi, Jawaher},
title = {Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report},
journal = {Psychopharmacology Bulletin},
year = {2026},
doi = {10.64719/pb.18543}
}
EUVIMED